John Ramage

Guidelines for the management of gastroenteropancreatic neuroendocrine (including carcinoid) tumours (NETs)

John Ramage, Alia Ahmed, J. Ardill et al. · Gut · 2011 · 951 citations · Full text

Medicine, Endocrinology, Oncology +13

Second-line FOLFOX chemotherapy versus active symptom control for advanced biliary tract cancer (ABC-06): a phase 3, open-label, randomised, controlled trial

Ángela Lamarca, Daniel H. Palmer, Harpreet Wasan et al. · The Lancet Oncology · 2021 · 749 citations · Full text

Medicine, Oncology, Pharmacology +8

ENETS Consensus Guidelines Update for Gastroduodenal Neuroendocrine Neoplasms

Gianfranco Delle Fave, Dermot O’Toole, Anders Sundín et al. · Neuroendocrinology · 2016 · 492 citations · Full text

Medicine, Oncology, Clinical Epidemiology +9

Thresholds for clinical importance were established to improve interpretation of the EORTC QLQ-C30 in clinical practice and research

Johannes M. Giesinger, Fanny L. Loth, Neil K. Aaronson et al. · Journal of Clinical Epidemiology · 2019 · 364 citations · Full text

Pharmacy, Oncology, Cancer Symptom Management +16

Guidelines for the management of gastroenteropancreatic neuroendocrine (including carcinoid) tumours

John Ramage · Gut · 2005 · 351 citations · Full text

Medicine, Oncology, Surgery +12